IRVINE, CA and AMSTERDAM, THE NETHERLANDS, February 4, 2013 – The MammaPrint breast cancer test can dramatically reduce the number of women who need to undergo chemotherapy to treat the disease, according to a newly published study.
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, February 4, 2013 – The MammaPrint breast cancer test can dramatically reduce the number of women who need to undergo chemotherapy to treat the disease, according to a newly published study.